A recent study revealed an important molecular role for hepatocyte-specific eNOS as a key target for NAFLD/non-alcoholic steatohepatitis (NASH) susceptibility, mitochondrial biogenesis, and inflammation attenuation (36, 37). Here, NOS3 is linked to metabolic dysfunction-associated steatohepatitis.